The abstract "One Year Follow up of Combined Autologous Bone Marrow Derived Progenitor Cell Therapy and Transmyocardial Laser Revascularization for Diffuse Nongraftable Coronary Artery Disease" can be located at: http://www.
What does TMLR stand for?
TMLR stands for Transmyocardial Laser Revascularization
This definition appears very rarely and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
- Tucson Mountain Little League (Arizona)
- Terrain Masking Low-Level Flight
- The Midlands Large Model Flying Group (UK)
- Too Much Light Makes the Baby Go Blind (theater show)
- Timeline, Inc. (stock symbol)
- That Means Lay Off
- The Marvelous Land of Oz (literature)
- Taunton Municipal Lighting Plant (Taunton, Massachusetts)
- Team Management and Leadership Program
- Thermal Margin Low Pressure (water reactors)
- Tactical Microwave Landing System
- Tenant Multiple Listing Service (housing database)
- Test for Multiple Latencies in Sleep (neurology)
- Text Message Listing System (Text You Back LLC)
- Textron Marine & Land Systems (division of Textron, Inc.; stock symbol TXT)
- The Mysterious Leinad Sicnarf (pseudonym for Daniel Francis)
- This Must Lead Somewhere (blog)
- Thurgood Marshall Legal Society (University of Texas)
- Texas Medical Liability Trust
- The Moon Landings Were Faked
Samples in periodicals archive:
Transmyocardial laser revascularization (TMR) is a treatment choice for patients who have refractory angina pectoris when bypass surgery or percutaneous transluminal angioplasty is not indicated.
Among their topics are the transcriptional regulation of angiogenesis, local and regional vascular delivery, protein growth factors in myocardial angiogenesis, current approaches and future directions in therapeutic angiogenesis for peripheral arterial disease, transplanting embryonic stem cells, and transmyocardial laser revascularization.
the leader in carbon dioxide (CO2) TransMyocardial Revascularization (TMR) technology used to treat severe angina, or heart pain, today announced that a study published in the May 2005 issue of The Journal of Thoracic and Cardiovascular Surgery reports an increase in angiogenesis within the heart as a result of a combination of revascularization therapies: CO2 transmyocardial laser revascularization plus matrix adenoviral fibroblast growth factor-2 (FGF-2) gene therapy.
Society of Thoracic Surgeons (STS) Workforce on Evidence-Based Surgery 2004; -- American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines 2002 (published 2003); -- Blue Cross and Blue Shield Association (BCBSA) Technology Evaluation Center Assessment on TMR as an Adjunct to CABG Surgery for the Treatment of Coronary Artery Disease 2001, reviewed in 2004; -- The Agency for Healthcare Research and Quality (AHRQ) Technology Assessment of Percutaneous Myocardial Laser Revascularization and Transmyocardial Laser Revascularization 2004; -- ECRI Technology Assessment Report on Transmyocardial Laser Revascularization (TMR)/ Percutaneous Myocardial Laser Revascularization (PMR) for Treatment of Refractory Angina 2004.
ECRI's recent technology assessment report examines the available published evidence on the effectiveness of surgical transmyocardial laser revascularization (TMR) and a more recent form of the procedure, percutaneous (catheter-based) myocardial revascularization (PMR) for treating angina, when compared to or combined with standard medical therapy.
29 /PRNewswire/ -- More cardiac surgeons are discovering the long-term benefits of carbon dioxide (CO2) Transmyocardial Laser Revascularization (TMR) therapy.
For those patients who continue to have heart pain, a therapy has emerged -- carbon dioxide (CO2) Transmyocardial Laser Revascularization (TMR).